Acute toxicity in patients with oligometastatic cancer following metastasis-directed stereotactic body radiotherapy: An interim analysis of the E 2 -RADIatE OligoCare cohort.
Filippo AlongiLuca NicosiaUmberto RicardiMarta ScorsettiDaniela GretoPanagiotis BalermpasYolande LievensPètra BraamBarbara Alicja Jereczek-FossaKarin StellamansIvica RatosaInga-Malin SimekHeike PeulenPiet DirixLuc VerbekeSara RamellaHossein HemmatazadKaouthar KhanfirXavier GeetsPaul JeeneThomas ZilliBeatrice FournierCatherine FortpiedFelix Boakye OppongPiet OstMatthias GuckenbergerPublished in: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology (2024)
OligoCare is the largest prospective registry cohort on oligometastatic disease. Acute toxicity within 6 months was low, confirming the safety of SBRT in the treatment of oligometastases.
Keyphrases
- liver failure
- respiratory failure
- radiation therapy
- drug induced
- oxidative stress
- aortic dissection
- papillary thyroid
- early stage
- hepatitis b virus
- radiation induced
- locally advanced
- young adults
- extracorporeal membrane oxygenation
- lymph node metastasis
- replacement therapy
- smoking cessation
- acute respiratory distress syndrome
- rectal cancer